Manuel Alejandro Rodriguez, | |
3600 Nw Samaritan Dr, Corvallis, OR 97330-5472 | |
(541) 768-4906 | |
Not Available |
Full Name | Manuel Alejandro Rodriguez |
---|---|
Gender | Male |
Speciality | Surgery |
Location | 3600 Nw Samaritan Dr, Corvallis, Oregon |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1851083950 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208600000X | Surgery | PG216315 (Oregon) | Primary |
Mailing Address | Practice Location Address |
---|---|
Manuel Alejandro Rodriguez, 3600 Nw Samaritan Dr, Corvallis, OR 97330-5472 Ph: (541) 768-4906 | Manuel Alejandro Rodriguez, 3600 Nw Samaritan Dr, Corvallis, OR 97330-5472 Ph: (541) 768-4906 |
News Archive
Novo Nordisk has completed a pre-specified meta-analysis based on the Degludec phase 3a trial programme. The meta-analysis confirmed that Degludec is associated with a lower risk of hypoglycaemia compared to insulin glargine, both on the total number of confirmed hypoglycaemic events, and on the number of confirmed nocturnal hypoglycaemic events. Both findings are statistically significant.
GenomeDx Biosciences today announced the publication of a positive validation study for the Decipher® Prostate Cancer Classifier, a genomic test for prostate cancer. The study, published in the Journal of Clinical Oncology, showed that patients with low genomic risk (as determined by Decipher) may be optimally managed with observation after radical prostatectomy (prostate surgery), while those with high genomic risk (as determined by Decipher) may be better managed earlier with adjuvant radiotherapy.
Researchers at The University of Texas M. D. Anderson Cancer Center have found that exercise decreases pain and helps breast cancer survivors feel healthier and increase participation in daily activities.
According to researchers in Holland people who are depressed are at an increased risk of developing Alzheimer's disease.
Dicerna Pharmaceuticals, Inc., a second generation RNA interference company developing novel therapeutics utilizing its proprietary Dicer Substrate Technologyâ„¢ and Dicer Substrate siRNA molecules, today announced that it has closed a $25 million Series B round of financing. New investor Domain Associates led the round, with all existing investors participating - Oxford Bioscience Partners, Skyline Ventures and Abingworth.
› Verified 4 days ago
Dr. Jeffrey David Crawford, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 3615 Nw Samaritan Dr Ste 201, Corvallis, OR 97330 Phone: 541-768-5930 | |
Mrs. Ashley Hennessey Mcmann, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 3600 Nw Samaritan Dr, Corvallis, OR 97330 Phone: 541-768-5111 | |
Dr. Yarrow J. Mcconnell, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 441 Nw Elks Dr Ste 101, Corvallis, OR 97330 Phone: 541-768-1252 | |
Spencer Larson Hill, DO Surgery Medicare: Medicare Enrolled Practice Location: 3600 Nw Samaritan Dr, Corvallis, OR 97330 Phone: 541-768-4906 | |
Russell W Hyde, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 3600 Nw Samaritan Dr, Corvallis, OR 97330 Phone: 541-768-5111 | |
Adena Zadourian, DO Surgery Medicare: Medicare Enrolled Practice Location: 3600 Nw Samaritan Dr, Corvallis, OR 97330 Phone: 541-768-5111 | |
Peter C Hudson, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 3680 Nw Samaritan Dr, Corvallis, OR 97330 Phone: 541-754-1150 |